Bristol-Myers Squibb's chief executive today gave no indication the company plans to increase its $4.3 billion offer for ImClone Systems, and he downplayed a higher, rival bid as "highly conditional." ...

NEW YORK - A federal judge today delayed by two months the sentencing of Samuel Waksal, the former chief executive of ImClone Systems Inc. ,on insider trading charges after chastising defense lawyers ...

NEW YORK -- Former ImClone Systems chief executive Samuel Waksal, whose arrest on insider trading charges has cast suspicion on Martha Stewart, was indicted Wednesday, apparently after attempts to cut ...

ImClone Systems Inc.'s high-water mark was a sweet deal last fall in which its shareholders were allowed to sell a portion of their holdings to drug giant Bristol-Myers Squibb Co. for $70 a share.

NEW YORK -- Clinical trial results for an experimental cancer drug, set to be released tomorrow, are expected to mark a new beginning for ImClone Systems Inc. after 18 months spent mired in scandal.